"Designing Growth Strategies is in our DNA"

Immunology Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Monoclonal antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal antibody (pAb), and Others); By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Regional

Region : Global | Format: PDF | Report ID: FBI100657

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Autoimmune and Immunological Disorders by Key Countries
    2. Overview of Regulatory Scenario by Key Regions
    3. Pipeline Analysis
    4. Key Industry Developments
    5. Overview of Current Advances in R&D for Immunology
    6. Overview of New Product Launches
    7. Impact of COVID-19 on Immunology Market
  5. Global Immunology Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibody (mAb)
      2. Fusion Proteins
      3. Immunosuppressants
      4. Polyclonal Antibody (pAb)
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Immunology Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibody (mAb)
      2. Fusion Proteins
      3. Immunosuppressants
      4. Polyclonal Antibody (pAb)
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Immunology Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibody (mAb)
      2. Fusion Proteins
      3. Immunosuppressants
      4. Polyclonal Antibody (pAb)
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Immunology Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibody (mAb)
      2. Fusion Proteins
      3. Immunosuppressants
      4. Polyclonal Antibody (pAb)
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Immunology Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibody (mAb)
      2. Fusion Proteins
      3. Immunosuppressants
      4. Polyclonal Antibody (pAb)
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Immunology Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibody (mAb)
      2. Fusion Proteins
      3. Immunosuppressants
      4. Polyclonal Antibody (pAb)
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast, Insights and Forecast – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Janssen Global Services, LLC (Johnson & Johnson)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Amgen Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Astellas
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Bristol-Myers Squibb Company
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Merck Sharp & Dohme Corp.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. UCB SA
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      11. ALLERGAN
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      12. Eli Lilly and Company
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)

List of Figures

Figure 01: Global Immunology Market Revenue Share (%), By Drug Class, 2020 & 2028

Figure 02: Global Immunology Market Revenue Share (%), by Disease Indication, 2020 & 2028

Figure 03: Global Immunology Market Revenue Share (%), by Distribution Channel, 2020 & 2028

Figure 04: Global Immunology Market Revenue Share (%), by Region, 2020 & 2028

Figure 05: North America Immunology Market Value (USD billion), by Country, 2020 & 2028

Figure 06: North America Immunology Market Revenue Share (%), by Country, 2020

Figure 07: North America Immunology Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 08: North America Immunology Market Revenue Share (%), by Drug Class, 2020

Figure 09: North America Immunology Market Value (USD billion), by Disease Indication, 2020 & 2028

Figure 10: North America Immunology Market Revenue Share (%), by Disease Indication, 2020

Figure 11: North America Immunology Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 12: North America Immunology Market Revenue Share (%), by Distribution Channel, 2020

Figure 13: Europe Immunology Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 14: Europe Immunology Market Revenue Share (%), by Country/Sub-region, 2020

Figure 15: Europe Immunology Market Value (USD billion), By Drug Class, 2020 & 2028

Figure 16: Europe Immunology Market Revenue Share (%), By Drug Class, 2020

Figure 17: Europe Immunology Market Value (USD billion), by Disease Indication, 2020 & 2028

Figure 18: Europe Immunology Market Revenue Share (%), by Disease Indication, 2020

Figure 19: Europe Immunology Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 20: Europe Immunology Market Revenue Share (%), by Distribution Channel, 2020

Figure 21: Asia Pacific Immunology Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 22: Asia Pacific Immunology Market Revenue Share (%), by Country/Sub-region, 2020

Figure 23: Asia Pacific Immunology Market Value (USD billion), By Drug Class, 2020 & 2028

Figure 24: Asia Pacific Immunology Market Revenue Share (%), By Drug Class, 2020

Figure 25: Asia Pacific Immunology Market Value (USD billion), by Disease Indication, 2020 & 2028

Figure 26: Asia Pacific Immunology Market Revenue Share (%), by Disease Indication, 2020

Figure 27: Asia Pacific Immunology Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 28: Asia Pacific Immunology Market Revenue Share (%), by Distribution Channel, 2020

Figure 29: Latin America Immunology Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 30: Latin America Immunology Market Revenue Share (%), by Country/Sub-region, 2020

Figure 31: Latin America Immunology Market Value (USD billion), By Drug Class, 2020 & 2028

Figure 32: Latin America Immunology Market Revenue Share (%), By Drug Class, 2020

Figure 33: Latin America Immunology Market Value (USD billion), by Disease Indication, 2020 & 2028

Figure 34: Latin America Immunology Market Revenue Share (%), by Disease Indication, 2020

Figure 35: Latin America Immunology Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 36: Latin America Immunology Market Revenue Share (%), by Distribution Channel, 2020

Figure 37: Middle East & Africa Immunology Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 38: Middle East & Africa Immunology Market Revenue Share (%), by Country/Sub-region, 2020

Figure 39: Middle East & Africa Immunology Market Value (USD billion), By Drug Class, 2020 & 2028

Figure 40: Middle East & Africa Immunology Market Revenue Share (%), By Drug Class, 2020

Figure 41: Middle East & Africa Immunology Market Value (USD billion), by Disease Indication, 2020 & 2028

Figure 42: Middle East & Africa Immunology Market Revenue Share (%), by Disease Indication, 2020

Figure 43: Middle East & Africa Immunology Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 44: Middle East & Africa Immunology Market Revenue Share (%), by Distribution Channel, 2020

Figure 45: Global Immunology Market Revenue Share Analysis (%), By Company, 2020

List of Tables

Table 01: Global Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2017-2028

Table 02: Global Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2017-2028

Table 03: Global Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 04: Global Immunology Market Revenue (USD billion) Forecast, by Region, 2017-2028

Table 05: North America Immunology Market Revenue (USD billion) Forecast, by Country, 2017-2028

Table 06: North America Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2017-2028

Table 07: North America Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2017-2028

Table 08: North America Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 09: Europe Immunology Market Revenue (USD billion) Forecast, by Country/Sub-region, 2017-2028

Table 10: Europe Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2017-2028

Table 11: Europe Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2017-2028

Table 12: Europe Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 13: Asia Pacific Immunology Market Revenue (USD billion) Forecast, by Country/Sub-region, 2017-2028

Table 14: Asia Pacific Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2017-2028

Table 15: Asia Pacific Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2017-2028

Table 16: Asia Pacific Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 17: Latin America Immunology Market Revenue (USD billion) Forecast, by Country/Sub-region, 2017-2028

Table 18: Latin America Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2017-2028

Table 19: Latin America Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2017-2028

Table 20: Latin America Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 21: Middle East & Africa Immunology Market Revenue (USD billion) Forecast, by Country/Sub-region, 2017-2028

Table 22: Middle East & Africa Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2017-2028

Table 23: Middle East & Africa Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2017-2028

 class=
  • Jun, 2021
  • 2020
  • 2017-2019
  • 149

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X